Join us as we speak to Dr. Lee Greenberger, the Chief Scientific Officer of The Leukemia & Lymphoma Society, and Dr. Larry Saltzman, the Executive Research Director of the LLS Patient Registry. In this episode, Dr. Greenberger and Dr. Saltzman provide important updates on the continued COVID-19 pandemic, the LLS Antibody Research Study, patients’ responses to the COVID vaccines, and additional methods of protection. Be sure to tune in to these important updates as LLS strives to protect patients.
Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | Stitcher | Blubrry | JioSaavn | TuneIn | RSS | MoreCLICK HERE to participate in our episode survey.
Mentioned on this episode:
- LLS Patient Registry
- LLS Antibody Study
- COVID Resources
- FDA Approved Monoclonal Antibodies – including Evusheld
- Ask The Expert in LLS Community *Membership (no cost) required
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Online chats
- Financial support
- Clinical Trial Support Center
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program Free Nutrition Consultations
As part of LLS’s COVID-19 Response Program, this podcast episode is supported in part by BeiGene, Bristol Myers Squibb, Kite, A Gilead Company, Pfizer and Pharmacyclics, An AbbVie Company & Janssen Biotech.